BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12376982)

  • 1. Localised Ewing sarcoma/PNET of bone--prognostic factors and international data comparison.
    Jenkin RD; Al-Fawaz I; Al-Shabanah M; Allam A; Ayas M; Khafaga Y; Memon M; Rifai S; Schultz H; Younge D
    Med Pediatr Oncol; 2002 Dec; 39(6):586-93. PubMed ID: 12376982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival after recurrence of Ewing tumors: the St Jude Children's Research Hospital experience, 1979-1999.
    Rodriguez-Galindo C; Billups CA; Kun LE; Rao BN; Pratt CB; Merchant TE; Santana VM; Pappo AS
    Cancer; 2002 Jan; 94(2):561-9. PubMed ID: 11900241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognosis in Ewing sarcoma patients with initial pathological fractures of the primary tumor site].
    Hoffmann C; Jabar S; Ahrens S; Rödl R; Rübe C; Winkelmann W; Dunst J; Jürgens H
    Klin Padiatr; 1995; 207(4):151-7. PubMed ID: 7564145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late events in pediatric patients with Ewing sarcoma/primitive neuroectodermal tumor of bone: the Dana-Farber Cancer Institute/Children's Hospital experience.
    McLean TW; Hertel C; Young ML; Marcus K; Schizer MA; Gebhardt M; Weinstein HJ; Perez-Atayde A; Grier HE
    J Pediatr Hematol Oncol; 1999; 21(6):486-93. PubMed ID: 10598659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma.
    Shankar AG; Ashley S; Craft AW; Pinkerton CR
    Med Pediatr Oncol; 2003 Mar; 40(3):141-7. PubMed ID: 12518341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
    Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE
    J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soft-tissue Ewing sarcoma in a low-incidence population: comparison to skeletal Ewing sarcoma for clinical characteristics and treatment outcome.
    Lee JA; Kim DH; Lim JS; Koh JS; Kim MS; Kong CB; Song WS; Cho WH; Lee SY; Jeon DG
    Jpn J Clin Oncol; 2010 Nov; 40(11):1060-7. PubMed ID: 20513751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group.
    Miser JS; Goldsby RE; Chen Z; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore SG; Rausen AR; Vietti TJ; Grier HE
    Pediatr Blood Cancer; 2007 Dec; 49(7):894-900. PubMed ID: 17584910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long-term review of the treatment of patients with Ewing's sarcoma in one institution.
    Sluga M; Windhager R; Lang S; Heinzl H; Krepler P; Mittermayer F; Dominkus M; Zoubek A; Kotz R
    Eur J Surg Oncol; 2001 Sep; 27(6):569-73. PubMed ID: 11520091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ewing's sarcoma in children--current surgical treatment options, evaluation of our patients].
    Schovanec J; Mrácek J; Havlas V; Trc T
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):220-7. PubMed ID: 15456100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A general aspect on soft-tissue sarcoma and c-kit expression in primitive neuroectodermal tumor and Ewing's sarcoma. Is there any role in disease process?
    Kara IO; Gonlusen G; Sahin B; Ergin M; Erdogan S
    Saudi Med J; 2005 Aug; 26(8):1190-6. PubMed ID: 16127511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term results following multidisciplinary treatment of localized Ewing's sarcoma in children and adolescents].
    Ullmann C; Beck JD; Holter W; Petsch S; Dunst J; Sauer R; Grabenbauer GG
    Strahlenther Onkol; 2008 Mar; 184(3):137-44. PubMed ID: 18330509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favorable outcome of Ewing sarcoma family tumors to multiagent intensive preoperative chemotherapy: a single institution experience.
    Moschovi M; Trimis G; Stefanaki K; Anastasopoulos J; Syriopoulou V; Koultouki E; Tzortzatou-Stathopoulou F
    J Surg Oncol; 2005 Mar; 89(4):239-43. PubMed ID: 15726621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous stem cell transplantation for high-risk Ewing's sarcoma and other pediatric solid tumors.
    Fraser CJ; Weigel BJ; Perentesis JP; Dusenbery KE; DeFor TE; Baker KS; Verneris MR
    Bone Marrow Transplant; 2006 Jan; 37(2):175-81. PubMed ID: 16273111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local and systemic control of Ewing's bone sarcoma family tumors of the ribs.
    Briccoli A; Rocca M; Salone M; Palmerini E; Balladelli A; Ferrari C; Di Fiore M; Bacci G
    J Surg Oncol; 2009 Sep; 100(3):222-6. PubMed ID: 19548266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors.
    Krasin MJ; Rodriguez-Galindo C; Billups CA; Davidoff AM; Neel MD; Merchant TE; Kun LE
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):830-8. PubMed ID: 15465200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ewing sarcoma: favourable results with combined modality therapy and conservative use of radiotherapy.
    Zogopoulos G; Teskey L; Sung L; Dix D; Grant R; Greenberg ML; Weitzman S
    Pediatr Blood Cancer; 2004 Jul; 43(1):35-9. PubMed ID: 15170887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in children with Ewing's sarcoma.
    Gehan EA; Nesbit ME; Burgert EO; Viettit J; Tefft M; Perez CA; Kissane J; Hempel C
    Natl Cancer Inst Monogr; 1981 Apr; (56):273-8. PubMed ID: 7029295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experience.
    Milano GM; Cozza R; Ilari I; De Sio L; Boldrini R; Jenkner A; De Ioris M; Inserra A; Dominici C; Donfrancesco A
    Cancer; 2006 Apr; 106(8):1838-45. PubMed ID: 16532434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ewing's sarcoma: value of tumor necrosis as a predictive factor.
    de Stéfani E; Carzoglio J; Deneo Pellegrini H; Olivera L; Cendan M; Kasdorf H
    Bull Cancer; 1984; 71(1):16-21. PubMed ID: 6713111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.